According to DBV Technologies's latest financial reports the company has a price-to-book ratio of 0.9218.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.39 | -6.28% |
2022-12-31 | 1.48 | -22.86% |
2021-12-31 | 1.92 | 65.69% |
2020-12-31 | 1.16 | -75.79% |
2019-12-31 | 4.78 | 107.49% |
2018-12-31 | 2.30 | -65.51% |
2017-12-31 | 6.68 | 5.73% |
2016-12-31 | 6.31 | 38.3% |
2015-12-31 | 4.57 | -23.92% |
2014-12-31 | 6.00 | |
2013-12-31 | N/A | |
2012-12-31 | N/A | |
2011-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Ionis Pharmaceuticals
IONS | 14.2 | 1,440.54% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -87.2 | -9,563.51% | ๐บ๐ธ USA |